290 related articles for article (PubMed ID: 25953156)
1. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
Choi M; Jo H; Park HJ; Sateesh Kumar A; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee K; Kwak JH; Lee H
Bioorg Med Chem Lett; 2015 Jun; 25(12):2545-9. PubMed ID: 25953156
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 2,3-dihydro- and 5-chloro-2,3-dihydro-naphtho-[1,2-b]furan-2-carboxylic acid N-(substitutedphenyl)amide analogs and their biological activities as inhibitors of NF-κB activity and anticancer agents.
Choi M; Jo H; Kim D; Yun J; Kang JS; Kim Y; Jung JK; Hong JT; Cho J; Kwak JH; Lee H
Arch Pharm Res; 2016 May; 39(5):618-30. PubMed ID: 27021311
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors.
Choi M; Hwang YS; Kumar AS; Jo H; Jeong Y; Oh Y; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee H
Bioorg Med Chem Lett; 2014 Jun; 24(11):2404-7. PubMed ID: 24792464
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and nuclear factor-kappaB inhibitory activities of 6- or 7-methylchroman-2-carboxylic acid N-(substituted) phenylamides.
Kwak JH; Won SW; Kim TJ; Yi W; Choi EH; Kim SC; Park H; Roh E; Jung JK; Hwang BY; Hong JT; Kim Y; Cho J; Lee H
Arch Pharm Res; 2009 Feb; 32(2):167-75. PubMed ID: 19280144
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of indoline-2-carboxylic acid N-(substituted)phenylamide derivatives.
Kwak JH; Kim Y; Park H; Jang JY; Lee KK; Yi W; Kwak JA; Park SG; Kim H; Lee K; Kang JS; Han SB; Hwang BY; Hong JT; Jung JK; Kim Y; Cho J; Lee H
Bioorg Med Chem Lett; 2010 Aug; 20(15):4620-3. PubMed ID: 20579876
[TBL] [Abstract][Full Text] [Related]
6. SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line.
Lim JC; Jeyaraj EJ; Sagineedu SR; Wong WS; Stanslas J
Pharmacology; 2015; 95(1-2):70-7. PubMed ID: 25613753
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative potency of novel benzofuran-2-carboxamides on tumour cell lines: cell death mechanisms and determination of crystal structure.
Hranjec M; Sović I; Ratkaj I; Pavlović G; Ilić N; Valjalo L; Pavelić K; Kraljević Pavelić S; Karminski-Zamola G
Eur J Med Chem; 2013 Jan; 59():111-9. PubMed ID: 23220640
[TBL] [Abstract][Full Text] [Related]
8. Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: design, synthesis and biological screening.
Suthar SK; Jaiswal V; Lohan S; Bansal S; Chaudhary A; Tiwari A; Alex AT; Joesph A
Eur J Med Chem; 2013 May; 63():589-602. PubMed ID: 23548704
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.
Sim S; Lee S; Ko S; Phuong Bui B; Linh Nguyen P; Cho J; Lee K; Kang JS; Jung JK; Lee H
Bioorg Med Chem; 2021 Sep; 46():116371. PubMed ID: 34500188
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of pregnenolone/2-cyanoacryloyl conjugates with dual NF-κB inhibitory and anti-proliferative activities.
Song JL; Zhang J; Liu CL; Liu C; Zhu KK; Yang FF; Liu XG; Figueiró Longo JP; Alexandre Muehlmann L; Azevedo RB; Zhang YY; Guo YW; Jiang CS; Zhang H
Bioorg Med Chem Lett; 2017 Oct; 27(20):4682-4686. PubMed ID: 28919340
[TBL] [Abstract][Full Text] [Related]
11. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.
Li N; Xin WY; Yao BR; Cong W; Wang CH; Hou GG
Eur J Med Chem; 2018 Jul; 155():531-544. PubMed ID: 29909338
[TBL] [Abstract][Full Text] [Related]
12. Rugulactone derivatives act as inhibitors of NF-κB activation and modulates the transcription of NF-κB dependent genes in MDA-MB-231cells.
Mohapatra DK; Reddy DS; Ramaiah MJ; Ghosh S; Pothula V; Lunavath S; Thomas S; Valli SN; Bhadra MP; Yadav JS
Bioorg Med Chem Lett; 2014 Mar; 24(5):1389-96. PubMed ID: 24508135
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of novel 2-thiophen-5-yl-3H-quinazolin-4-one analogues as inhibitors of transcription factors NF-kappaB and AP-1 mediated transcriptional activation: Their possible utilization as anti-inflammatory and anti-cancer agents.
Giri RS; Thaker HM; Giordano T; Williams J; Rogers D; Vasu KK; Sudarsanam V
Bioorg Med Chem; 2010 Apr; 18(7):2796-808. PubMed ID: 20335039
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents.
Kumar V; Mudgal MM; Rani N; Jha A; Jaggi M; Singh AT; Sanna VK; Singh P; Sharma PK; Irchhaiya R; Burman AC
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):763-70. PubMed ID: 18720190
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of dihydrobenzofuran lignans and related compounds as potential antitumor agents that inhibit tubulin polymerization.
Pieters L; Van Dyck S; Gao M; Bai R; Hamel E; Vlietinck A; Lemière G
J Med Chem; 1999 Dec; 42(26):5475-81. PubMed ID: 10639289
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of substituted 11H-benzo[a]carbazole-5-carboxamides as novel antitumor agents.
Wang YQ; Li XH; He Q; Chen Y; Xie YY; Ding J; Miao ZH; Yang CH
Eur J Med Chem; 2011 Dec; 46(12):5878-84. PubMed ID: 22000922
[TBL] [Abstract][Full Text] [Related]
17. SAR studies of 2-arylthiazolidine-4-carboxylic acid amides: a novel class of cytotoxic agents for prostate cancer.
Gududuru V; Hurh E; Sullivan J; Dalton JT; Miller DD
Bioorg Med Chem Lett; 2005 Sep; 15(18):4010-3. PubMed ID: 16005217
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran-pyrazole derivatives as anticancer agents.
Abd El-Karim SS; Anwar MM; Mohamed NA; Nasr T; Elseginy SA
Bioorg Chem; 2015 Dec; 63():1-12. PubMed ID: 26368040
[TBL] [Abstract][Full Text] [Related]
19. Benzofuran derivatives as anticancer inhibitors of mTOR signaling.
Salomé C; Ribeiro N; Chavagnan T; Thuaud F; Serova M; de Gramont A; Faivre S; Raymond E; Désaubry L
Eur J Med Chem; 2014 Jun; 81():181-91. PubMed ID: 24836070
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological activity of a novel series of benzofuran derivatives against oestrogen receptor-dependent breast cancer cell lines.
Jin LP; Xie Q; Huang EF; Wang L; Zhang BQ; Hu JS; Wan DC; Jin Z; Hu C
Bioorg Chem; 2020 Jan; 95():103566. PubMed ID: 31935604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
